Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDRN for Rotator Cuff Healing After Surgery
NCT03916198Phase 4Completed
- Sponsor
- Hallym University Chuncheon Sacred Heart Hospital
- Start
- May 2019
- Primary completion
- Aug 2021
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of polideoxirybonucleotide in rotator cuff tear, sponsored by Hallym University Chuncheon Sacred Heart Hospital. Primary endpoint: American Shoulder and Elbow at 24 months. Started May 2019; status: completed.
02
Drugs
polideoxirybonucleotide
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT03916198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03916198.